Navigation Links
Chinese Pharma Giant Launches Mobile Phone Anti-Counterfeiting Crusade in Africa
Date:5/15/2013

Shanghai, China (PRWEB) May 15, 2013

Guilin Pharmaceuticals, the World’s first producer of artesunate prequalified by the World Health Organisation as meeting the global body’s stringent standards for safety, quality and efficacy, has chalked another first.

The company, which manages the world’s largest vertically integrated artemisinin production system, has become the first Chinese company to introduce an SMS-based system for African consumers and patients of its medicines to confirm the authenticity of their Guilin-produced anti-malarials.

Buyers of a wide range of Guilin anti-malarials shall be able to scratch-off a special layer covering a unique ID, which they can then send off in a free text message to a special hotline number for instant feedback on the authenticity of the pack.

The service, which shall initially be available to all 50 million mobile subscribers in Nigeria, before being extended to other African countries, comes in the wake of a massive global outcry about the impact of counterfeiting on the world’s malaria situation.

Counterfeiting is believed to be contributing to the emergence and spread of newer, more virulent, drug-resistant malarial parasites that are harder and much more expensive to treat, thus raising the risk of death for many patients around the world.

Guilin’s new anti-counterfeiting program integrates the company’s extensive, in-house, brand protection measures with the Goldkeys© telecom and cloud computing platform provided by the mPedigree Network [http://www.mPedigree.Net , a global social enterprise working to end the trade in counterfeit medicines in Africa and South Asia. This would be the first time the Goldkeys© technology is being deployed in the Chinese pharmaceutical supply chain. The Goldkeys© protocol has been supported by global technology companies such as Hewlett Packard and Orange Health. Selorm Branttie, Market Strategy Lead at mPedigree Network, described Guilin’s adoption of Goldkeys© as “a milestone of remarkable importance in the global fight against malaria.”

10 million patients are expected to benefit from the program in the first phase of implementation in the 2013 – 2014 operational year.

Ms. Lily Su, Guilin’s Vice President, said: “As a company devoted to the highest standards of technical excellence, we are always keen to emphasise that for us the patient, not science, comes first. Our approach is always to go to every conceivable extent to ensure that those who use our medicines become the central fulcrum around which all our activities turn. This new technology leverages the most empowering device in Africa today – the mobile phone – as an additional layer of a powerful patient-empowerment strategy that includes our safety and quality feedback management system.”

About Guilin Pharmaceuticals
Founded in 2008, Guilin Pharmaceutical (Shanghai) Co., Ltd. (GPSC) is a subsidiary of Guilin Pharmaceutical Co., Ltd. as well as a member of Fosun Pharmaceutical Group. Focusing on international market business, Guilin develops, produce and market various kinds of pharmaceutical products, including anti-malarials, and generic pharmaceuticals. Guilin market its products in developing countries, and supply its products to clients all over the world, such as WHO, UNICEF, ICRC, MSF, as well as other governmental, profit- and non-profit organizations. As the only pharmaceutical company GMP pre-qualified by WHO to produce Artemisinin-based therapies, Guilin Pharma has established the most integrated industry chain for this category of malaria medicines across the Globe.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10735508.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DNA Testing Finds Allergens, Toxins in Traditional Chinese Medicines
2. EB-5 Expert Brian Su Explores Chinese Inbound Investments in Southern California
3. Tai Chi increases brain size, benefits cognition in randomized controlled trial of Chinese elderly
4. San Francisco EB-5 Conference explores inbound Chinese investments
5. Chinese Drywall Complaint Center Now Demands Leadership From Obama & EPA, For Homeowners In Florida And In The US Southeast Stuck In Toxic Chinese Drywall Hell-Forward?
6. Feinstein Institute researchers discover that bean used in Chinese food could protect against sepsis
7. Chinese Herbal Medicine Can Reach into Prostate Gland and Treat Prostatitis Successfully As A New Option for Prostatitis Sufferers, States Wuhan Dr.Li's Clinic
8. Residents near Chinese e-waste site face greater cancer risk
9. Indoor air puts Chinese women nonsmokers at risk
10. Launch of Chinese-German Center for Bio-Inspired Materials at Mainz University Medical Center
11. Traditional Chinese Medicine Hospitals in China Industry Research Report – Now Available from IBISWorld
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... 02, 2016 , ... ‘Tis the season for giving! Today, 20 creative teams ... Family Partnership and the Drug Enforcement Administration as part of the National Red Ribbon ... winning schools who decorated their campuses with this year’s Red Ribbon Week theme: “YOLO. ...
(Date:11/30/2016)... ... November 30, 2016 , ... Northridge ... in-house dental plan for all patients. Understanding that budget can play a part ... a number of perks, including discounts on many valuable dental treatments. Options for ...
(Date:11/30/2016)... Wisconsin (PRWEB) , ... November 30, 2016 , ... ... in the 2016 Deloitte Wisconsin 75, an annual ranking and recognition of the ... year on the list, having ranked from 2008-2016. In addition, Standard Process was ...
(Date:11/30/2016)... (PRWEB) , ... November 30, 2016 , ... ... and mental health treatment has announced the opening of a new residential mental ... for girls with mental health issues such as severe anxiety, depression, bi-polar disorder, ...
(Date:11/30/2016)... ... November 30, 2016 , ... The ... stylish design wanted by today’s consumers at an affordable price, is now available ... the new watch is “a game changer” when it comes to the smartwatch. ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , December 2, 2016 ... "In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, ... Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - ... market is valued at USD 60.22 Billion in ... a CAGR of 5.5% during the forecast period ...
(Date:12/2/2016)... 2016  The Addiction Treatment Advisory Group (ATAG), ... Care Pharmacy (AMCP), has released detailed findings on ... opioid addiction crisis, including through improved access to ... ATAG,s newly released paper, "The Role of Managed ... many issues around gaps and barriers to addiction ...
(Date:12/2/2016)... 2, 2016 Boston Scientific Corporation (NYSE: ... acquire certain manufacturing assets and capabilities of the Neovasc, ... biological tissue business, as well as a 15% equity ... in cash. The Neovasc advanced biological tissue business makes ... Scientific Lotus™ Valve System. * Upon completion of ...
Breaking Medicine Technology: